Autori: Ratchford John
| Naslov | Fenebrutinib maintains early and sustained low disease activity in patients with relapsing multiple sclerosis: 2-year results from the FENopta open-label extension (Meeting Abstract) |
| Autori | Oh Jiwon Drulovic Jelena S Dufek Michal Budincevic Hrvoje Habek Mario Caunt Maresa Cheng Ying-Fang Harp Christopher Sierzega Malgorzata Clayton David Ratchford John Goodyear Alexandra Bar-Or Amit |
| Info | MULTIPLE SCLEROSIS JOURNAL, (2025), vol. 31 br. 3, Suppl. S, str. 109-109 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa |
| Naslov | Fenebrutinib maintains low disease activity in relapsing multiple sclerosis: results from the FENopta trial open-label extension (Meeting Abstract) |
| Autori | Bar-Or Amit Oh Jiwon Dufek Michal Budincevic Hrvoje Habek Mario Caunt Maresa Thomas Piia Sierzega Malgorzata Clayton David Cheng Ying Fang Ratchford John Goodyear Alexandra Drulovic Jelena S |
| Info | MULTIPLE SCLEROSIS JOURNAL, (2024), vol. 30 br. 3, Suppl. S, str. 1021-1022 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa |
| Naslov | Efficacy and Safety of Fenebrutinib, a Noncovalent, Reversible BTK inhibitor, in MS: Primary Results of a Phase 2 Trial (Meeting Abstract) |
| Autori | Hua Le Bar-Or Amit Weber Martin Habek Mario Budincevic Hrvoje Thomas Piia Napieralski Julie Ratchford John Qi Qi Sierzega M Drulovic Jelena S |
| Info | EUROPEAN JOURNAL OF NEUROLOGY, (2023), vol. 30 br. , Suppl. 1, str. - |
| Ispravka | ISI/Web of Science Elečas Rang časopisa |
